BUPROPION HYDROCHLORIDE (SR)
Generic: BUPROPION HYDROCHLORIDE
Cipla USA Inc.Manufacturer
ORALRoute
BUPROPION HYDROCHLORIDEActive Substance
2016-02-09Original Approval
BUPROPION HYDROCHLORIDE (SR) is FDA application ANDA206674, sponsored by INVAGEN PHARMS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class III2018-03-15
buPROPion HCl Extended-Release Tablets, USP (SR), 150 mg ,a) 60 count (NDC 69097-878-03) and b) 100 count (NDC 69097-Failed Dissolution Specifications; during stability testing
Class III2018-03-15
buPROPion HCl Extended-Release Tablets, USP (SR), 100 mg, 60 count bottles, Rx Only, Manufactured for: Cipla USA Inc. Failed Dissolution Specifications; during stability testing
Top Reported Reactions
1
DRUG INEFFECTIVE
1,998 reports
2
HEADACHE
1,481 reports
3
FATIGUE
1,365 reports
4
DEPRESSION
1,350 reports
5
NAUSEA
1,200 reports
6
OFF LABEL USE
1,063 reports
7
PAIN
966 reports
8
INTENTIONAL OVERDOSE
922 reports
9
ANXIETY
885 reports
10
DRUG INTERACTION
865 reports